latest news

The power of combining DREADD and PET imaging technologies to be presented for the first time at BrainPET Berlin 2017

neuronsDREADD (Designer Receptors Exclusively Activated by Designer Drugs) technology is an exciting chemog...
read full article

Further Growth in Imanova’s Preclinical Biology Offering

Imanova is pleased to announce further expansion of its preclinical team, with the addition of new r...
read full article

Imanova choses the Down’s Syndrome Association as Charity of the Year

Imanova as selected the national charity, the Down’s Syndrome Association (DSA) as their Charity of ...
read full article

Imanova appoints Preclinical Business Development Manager

Imanova continues to grow its preclinical offering, to respond to an increased demand from the pharm...
read full article

Molecular Imaging Analysis for Tracer Validation and Clinical Trials - video presentation

Roger Gunn, CSO at Imanova, was this year's invited lecturer at the Human Amyloid Imaging Conference...
read full article

Archive